Integrins in Drug Targeting-RGD Templates in Toxins
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2749-2769
Author(s):
X. Lu, D. Lu, M. F. Scully and V. V. Kakkar
Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2833-2848
Author(s):
Mary A. Bewick and Robert M. Lafrenie
Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
2849-2861
Author(s):
Konstantinos N. Syrigos and Anastasios J. Karayiannakis
Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3117-3133
Author(s):
G. Perletti and D. M. Terrian
Cannabinoids, Immune System and Cytokine Network
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3135-3146
Author(s):
P. Massi, A. Vaccani and D. Parolaro
Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy
Journal:
Current Drug Safety
Volume:
1
Page:
253-257
Author(s):
Thomas Wirth, Marja Hedman, Kimmo Makinen, Hannu Manninen, Arto Immonen, Matti Vapalahti and Seppo Yla-Herttuala
Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Journal:
Current Immunology Reviews (Discontinued)
Volume:
2
Page:
261-272
Author(s):
Gopal Murugaiyan, Saroj Basak and Bhaskar Saha
Immunotherapy of Cancer Based on DC-Tumor Fusion Vaccine
Journal:
Current Immunology Reviews (Discontinued)
Volume:
2
Page:
291-304
Author(s):
Jianlin Gong
Rho GTPase Activating Proteins in Cancer Phenotypes
Journal:
Current Protein & Peptide Science
Volume:
7
Page:
355-365
Author(s):
Raj P. Kandpal
Glycoconjugates: Roles in Neural Diseases Caused by Exogenous Pathogens
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
5
Page:
381-389
Author(s):
Cara-Lynne Schengrund